Thomas Niel

Thomas Niel

Expertise: Micro-Cap Stocks, Shareholder Activist Stocks, Value Stocks

Education: Bachelors in Accounting, CFA Program Participant (Completed Level I in 2017)

About Thomas:
Thomas Niel is an investment writer at InvestorPlace. With a professional background in accounting and financial analysis, his understanding of both words and figures pays dividends when writing clear, concise stock analysis.

A value investor at heart, Thomas looks at the fundamentals. Peer analysis and earnings multiples rarely tell the whole story. But, Thomas believes valuation metrics are a great starting point to separate the wheat from the chaff.

His work has appeared at several websites, including Seeking Alpha and TipRanks. Outside of investment research, Thomas provides inbound marketing content to the investment management industry.

You can follow Thomas on Twitter and check out his track record on TipRanks.

Recent Articles

Rebounding Teva Stock Could Climb Higher, But Risks Remain

The TEVA stock price has rebounded on a potential opioid settlement. But consider the company's other risks before buying Teva.

Advanced Micro Devices Stock Is Overvalued, But Could Climb Higher

The upside for Advanced Micro Devices stock is already priced into shares. But continued investor enthusiasm could send AMD stock higher.

‘Cannabis 2.0’ May Not Be Enough to Save Canopy Growth Stock

"Cannabis 2.0" could be the catalyst to save CGC stock. But other factors remain at play. Tread carefully before buying Canopy Growth stock.

PLUG Stock Keeps Getting Hotter, but Shareholders Should Tread Lightly

Plug Power could meet its audacious growth goals. But with high dilution, upside in PLUG stock may be limited. Keep this in mind before entering a position.

With Altria in the Driver’s Seat, It’s Tough to Play Cronos Stock

This makes it tough for average investors to win with Cronos stock. On the other hand, high-short interest may mean its too late to go short CRON. The company's shares could rally in a short squeeze scenario. So what's your play with Cronos stock? Avoid!